CLSD(Delisted)
Clearside Biomedical·NASDAQ
--
--(--)
Clearside Biomedical (CLSD) Financial Statements
Clearside Biomedical (CLSD) Cash Flow Statement
During Q3 2025, Clearside Biomedical (CLSD) generated -5.48M in cash flow from operating activities, 0 from investing activities, and 2.90M from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2015 | Q1,2016 | Q1,2017 | Q1,2018 | Q1,2019 | Q1,2020 | Q1,2021 | Q1,2022 | Q1,2023 | Q4,2023 | Q1,2024 | Q2,2024 | Q3,2024 | Q4,2024 | Q1,2025 | Q2,2025 | Q3,2025 | TTM |
|---|
Start Date | Jan 1, 2015 | Jan 1, 2016 | Jan 1, 2017 | Jan 1, 2018 | Jan 1, 2019 | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2023 | Oct 1, 2023 | Jan 1, 2024 | Apr 1, 2024 | Jul 1, 2024 | Oct 1, 2024 | Jan 1, 2025 | Apr 1, 2025 | Jul 1, 2025 | -- |
End Date | Mar 31, 2015 | Mar 31, 2016 | Mar 31, 2017 | Mar 31, 2018 | Mar 31, 2019 | Mar 31, 2020 | Mar 31, 2021 | Mar 31, 2022 | Mar 31, 2023 | Dec 31, 2023 | Mar 31, 2024 | Jun 30, 2024 | Sep 30, 2024 | Dec 31, 2024 | Mar 31, 2025 | Jun 30, 2025 | Sep 30, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -3.75M -- | -4.40M -17.29% | -10.98M -149.73% | -15.65M -42.59% | -12.65M +19.17% | -2.80M +77.85% | -5.56M -98.32% | 3.87M +169.63% | -7.22M -286.41% | 495.00K -- | -7.85M -8.80% | -5.68M -- | -5.91M -- | -5.25M -1161.41% | -5.83M +25.74% | -4.73M +16.74% | -5.48M +7.32% | -21.29M -- |
Net Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -4.83M -- | -11.76M -- | -7.59M -- | -7.69M -- | -7.31M -51.20% | -8.22M +30.09% | -4.50M +40.81% | -5.97M +22.33% | -26.00M -- |
Depreciation and Amortization | 15.00K -- | 17.00K +13.33% | 48.00K +182.35% | 47.00K -2.08% | 53.00K +12.77% | 45.00K -15.09% | 45.00K -- | 46.00K +2.22% | 15.00K -67.39% | 20.00K -- | 28.00K +86.67% | 44.00K -- | 75.00K -- | 79.00K +295.00% | 85.00K +203.57% | 84.00K +90.91% | 84.00K +12.00% | 332.00K -- |
Stock-based Compensation | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.03M -- | 1.06M -- | 1.12M -- | 1.17M -- | 1.17M +13.65% | 721.00K -32.11% | 694.00K -38.04% | 746.00K -35.97% | 3.33M -- |
Interest Income(expense) | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 2.28M -- | 2.40M -- | 2.34M -- | 2.46M -- | 2.58M +13.21% | 2.67M +11.24% | 2.76M +18.03% | 2.57M +4.60% | 10.58M -- |
Change in Working Capital | -174.00K -- | 719.00K +513.22% | -1.50M -308.62% | -260.00K +82.67% | 1.49M +674.23% | -969.00K -164.90% | 1.59M +264.19% | 10.16M +538.72% | -1.16M -111.41% | 2.00M -- | -1.08M +6.82% | 437.00K -- | -1.38M -- | 346.00K -82.73% | -879.00K +18.61% | -2.05M -570.02% | 665.00K +148.19% | -1.92M -- |
Change in Deferred Revenue | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 75.00K -- | 75.00K -- | 75.00K -- | -225.00K -- | 0 -100.00% | 0 -100.00% | 0 -100.00% | 0 +100.00% | -- -- |
Change in Other Working Capital | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 1.93M -- | -1.16M -- | 362.00K -- | -1.16M -- | 346.00K -82.05% | -879.00K +23.90% | -2.05M -667.40% | 665.00K +157.58% | -1.92M -- |
Other Non-cash Adjustments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 1.50M -- | -2.03M -- | -541.00K -- | -2.12M -- | -207.00K -113.81% | -1.72M +15.15% | -3.57M -560.44% | -7.62M -- |
Net Cash Flows from Investing Activities | -- -- | -- -- | -5.99M -- | 12.24M +304.42% | 30.93M +152.61% | -55.00K -100.18% | 0 +100.00% | 0 -- | -115.00K -- | -120.00K -- | -57.00K +50.43% | -11.44M -- | 1.55M -- | 9.31M +7855.83% | -9.00K +84.21% | 0 +100.00% | 0 -100.00% | 9.30M -- |
Change in PPE and Intangible Assets | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -120.00K -- | -57.00K -- | -423.00K -- | -53.00K -- | -444.00K -270.00% | -9.00K +84.21% | 0 +100.00% | 0 +100.00% | -453.00K -- |
Purchase of PPE and Intangible Assets | -- -- | -- -- | 309.00K -- | -- -- | 18.00K -- | 55.00K +205.56% | -- -- | 0 -- | 115.00K -- | 120.00K -- | 57.00K -50.43% | 423.00K -- | 53.00K -- | 444.00K +270.00% | 9.00K -84.21% | 0 -100.00% | 0 -100.00% | 453.00K -- |
Change in Investments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -11.01M -- | 1.60M -- | 9.75M -- | -- -- | 0 +100.00% | 0 -100.00% | -- -- |
Decrease in Investments | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | -- -- | 7.50M -- | 9.75M -- | -- -- | -- -- | 0 -100.00% | -- -- |
Increase in Investments | -- -- | -- -- | 12.66M -- | 8.72M -31.06% | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 11.01M -- | 5.90M -- | -1.00K -- | -- -- | 0 -100.00% | 0 -100.00% | -- -- |
Net Cash Flows from Financing Activities | -- -- | -- -- | 5.13M -- | 79.02M +1439.41% | 6.63M -91.61% | 1.19M -82.00% | 14.42M +1108.63% | 65.00K -99.55% | 332.00K +410.77% | -257.00K -- | 14.34M +4220.18% | 0 -- | 14.00K -- | 2.08M +908.95% | -553.00K -103.86% | 477.00K -- | 2.90M +20650.00% | 4.91M -- |
Change in Capital Stock | -- -- | -- -- | -- -- | 237.00K -- | 1.00K -99.58% | -- -- | 54.00K -- | 62.00K +14.81% | 37.00K -40.32% | 743.00K -- | 14.34M +38664.86% | 0 -- | 14.00K -- | 2.08M +179.81% | 447.00K -96.88% | 977.00K -- | 10.00K -28.57% | 3.51M -- |
Increase in Capital Stock | -- -- | -- -- | -- -- | 237.00K -- | 1.00K -99.58% | -- -- | 54.00K -- | 62.00K +14.81% | 37.00K -40.32% | 743.00K -- | 14.34M +38664.86% | 0 -- | 14.00K -- | 2.08M +179.81% | 447.00K -96.88% | 977.00K -- | 10.00K -28.57% | 3.51M -- |
Other Financing Activities | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -1.00M -- | 0 -- | 0 -- | 0 -- | 0 +100.00% | -1.00M -- | -500.00K -- | 2.90M -- | 1.40M -- |
Net Increase in Cash and Cash Equivalents | -3.75M -- | -4.40M -17.29% | -11.84M -169.22% | 75.61M +738.87% | 24.91M -67.06% | -1.67M -106.68% | 8.86M +632.13% | 3.94M -55.58% | -7.00M -277.82% | 118.00K -- | 6.43M +191.94% | -17.12M -- | -4.35M -- | 6.13M +5096.61% | -6.39M -199.33% | -4.25M +75.16% | -2.58M +40.80% | -7.09M -- |
Cash and Cash Equivalents at Beginning of Period | 8.27M -- | 20.28M +145.29% | 35.18M +73.47% | 9.58M -72.76% | 8.40M -12.32% | 22.95M +173.18% | 17.65M -23.12% | 30.70M +73.94% | 48.42M +57.73% | 28.80M -- | 28.92M -40.27% | 35.35M -- | 18.24M -- | 13.89M -51.78% | 20.02M -30.77% | 13.63M -61.45% | 9.38M -48.59% | 56.91M -- |
Cash and Cash Equivalents at End of Period | 4.52M -- | 15.89M +251.40% | 23.35M +46.97% | 85.19M +264.87% | 33.31M -60.90% | 21.29M -36.09% | 26.51M +24.50% | 34.63M +30.65% | 41.42M +19.60% | 28.92M -- | 35.35M -14.64% | 18.24M -- | 13.89M -- | 20.02M -30.77% | 13.63M -61.45% | 9.38M -48.59% | 6.80M -51.03% | 49.83M -- |
You can ask Aime
No Data
